vs
Kontoor Brands, Inc.（KTB）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Kontoor Brands, Inc.的季度营收约是Royalty Pharma plc的1.4倍（$853.2M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 4.3%，领先30.1%），Kontoor Brands, Inc.同比增速更快（27.3% vs 4.8%），过去两年Kontoor Brands, Inc.的营收复合增速更高（14.2% vs 4.6%）
Kontoor Brands是美国知名服装企业，2019年5月从威富集团分拆独立运营，旗下拥有Lee、Wrangler、Helly Hansen等国际知名服饰品牌，面向全球市场销售各类服饰产品，在休闲服饰及户外功能服饰领域拥有广泛的消费者基础。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
KTB vs RPRX — 直观对比
营收规模更大
KTB
是对方的1.4倍
$622.0M
营收增速更快
KTB
高出22.5%
4.8%
净利率更高
RPRX
高出30.1%
4.3%
两年增速更快
KTB
近两年复合增速
4.6%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $853.2M | $622.0M |
| 净利润 | $36.9M | $214.2M |
| 毛利率 | 41.3% | — |
| 营业利润率 | 7.5% | 62.4% |
| 净利率 | 4.3% | 34.4% |
| 营收同比 | 27.3% | 4.8% |
| 净利润同比 | -47.6% | 2.9% |
| 每股收益（稀释后） | $0.66 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KTBRPRX
| Q4 25 | — | $622.0M | ||
| Q3 25 | $853.2M | $609.3M | ||
| Q2 25 | $658.3M | $578.7M | ||
| Q1 25 | $622.9M | $568.2M | ||
| Q4 24 | $699.3M | $593.6M | ||
| Q3 24 | $670.2M | $564.7M | ||
| Q2 24 | $606.9M | $537.3M | ||
| Q1 24 | $631.2M | $568.0M |
净利润KTBRPRX
| Q4 25 | — | $214.2M | ||
| Q3 25 | $36.9M | $288.2M | ||
| Q2 25 | $73.9M | $30.2M | ||
| Q1 25 | $42.9M | $238.3M | ||
| Q4 24 | $64.0M | $208.2M | ||
| Q3 24 | $70.5M | $544.0M | ||
| Q2 24 | $51.8M | $102.0M | ||
| Q1 24 | $59.5M | $4.8M |
毛利率KTBRPRX
| Q4 25 | — | — | ||
| Q3 25 | 41.3% | — | ||
| Q2 25 | 46.3% | — | ||
| Q1 25 | 47.5% | — | ||
| Q4 24 | 43.7% | — | ||
| Q3 24 | 44.7% | — | ||
| Q2 24 | 44.7% | — | ||
| Q1 24 | 45.2% | — |
营业利润率KTBRPRX
| Q4 25 | — | 62.4% | ||
| Q3 25 | 7.5% | 70.1% | ||
| Q2 25 | 11.9% | 36.3% | ||
| Q1 25 | 11.8% | 94.0% | ||
| Q4 24 | 12.1% | 60.9% | ||
| Q3 24 | 14.7% | — | ||
| Q2 24 | 12.4% | 50.2% | ||
| Q1 24 | 13.4% | -13.0% |
净利率KTBRPRX
| Q4 25 | — | 34.4% | ||
| Q3 25 | 4.3% | 47.3% | ||
| Q2 25 | 11.2% | 5.2% | ||
| Q1 25 | 6.9% | 41.9% | ||
| Q4 24 | 9.1% | 35.1% | ||
| Q3 24 | 10.5% | 96.3% | ||
| Q2 24 | 8.5% | 19.0% | ||
| Q1 24 | 9.4% | 0.8% |
每股收益（稀释后）KTBRPRX
| Q4 25 | — | $0.49 | ||
| Q3 25 | $0.66 | $0.67 | ||
| Q2 25 | $1.32 | $0.07 | ||
| Q1 25 | $0.76 | $0.55 | ||
| Q4 24 | $1.13 | $0.46 | ||
| Q3 24 | $1.26 | $1.21 | ||
| Q2 24 | $0.92 | $0.23 | ||
| Q1 24 | $1.05 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.4M | $618.7M |
| 总债务越低越好 | $1.3B | $9.0B |
| 股东权益账面价值 | $529.6M | $9.7B |
| 总资产 | $2.9B | $19.6B |
| 负债/权益比越低杠杆越低 | 2.53× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资KTBRPRX
| Q4 25 | — | $618.7M | ||
| Q3 25 | $82.4M | $938.9M | ||
| Q2 25 | $107.5M | $631.9M | ||
| Q1 25 | $356.7M | $1.1B | ||
| Q4 24 | $334.1M | $929.0M | ||
| Q3 24 | $269.4M | $950.1M | ||
| Q2 24 | $224.3M | $1.8B | ||
| Q1 24 | $215.1M | $843.0M |
总债务KTBRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | $1.3B | $8.9B | ||
| Q2 25 | $1.4B | $8.0B | ||
| Q1 25 | $735.6M | $7.6B | ||
| Q4 24 | $740.3M | $7.6B | ||
| Q3 24 | $745.0M | $7.6B | ||
| Q2 24 | $749.7M | $7.6B | ||
| Q1 24 | $779.2M | $6.1B |
股东权益KTBRPRX
| Q4 25 | — | $9.7B | ||
| Q3 25 | $529.6M | $9.6B | ||
| Q2 25 | $498.3M | $9.5B | ||
| Q1 25 | $426.7M | $9.8B | ||
| Q4 24 | $400.1M | $10.3B | ||
| Q3 24 | $356.9M | $10.3B | ||
| Q2 24 | $367.2M | $9.8B | ||
| Q1 24 | $387.2M | $9.9B |
总资产KTBRPRX
| Q4 25 | — | $19.6B | ||
| Q3 25 | $2.9B | $19.3B | ||
| Q2 25 | $2.7B | $18.3B | ||
| Q1 25 | $1.7B | $17.6B | ||
| Q4 24 | $1.7B | $18.2B | ||
| Q3 24 | $1.7B | $18.0B | ||
| Q2 24 | $1.6B | $17.7B | ||
| Q1 24 | $1.7B | $16.1B |
负债/权益比KTBRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | 2.53× | 0.93× | ||
| Q2 25 | 2.74× | 0.84× | ||
| Q1 25 | 1.72× | 0.78× | ||
| Q4 24 | 1.85× | 0.74× | ||
| Q3 24 | 2.09× | 0.74× | ||
| Q2 24 | 2.04× | 0.78× | ||
| Q1 24 | 2.01× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $64.1M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $55.8M | — |
| 自由现金流率自由现金流/营收 | 6.5% | — |
| 资本支出强度资本支出/营收 | 1.0% | — |
| 现金转化率经营现金流/净利润 | 1.74× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $228.0M | — |
8季度趋势，按日历期对齐
经营现金流KTBRPRX
| Q4 25 | — | $827.1M | ||
| Q3 25 | $64.1M | $702.6M | ||
| Q2 25 | $25.7M | $364.0M | ||
| Q1 25 | $77.6M | $596.1M | ||
| Q4 24 | $82.0M | $742.5M | ||
| Q3 24 | $133.6M | $703.6M | ||
| Q2 24 | $96.2M | $658.2M | ||
| Q1 24 | $56.5M | $664.6M |
自由现金流KTBRPRX
| Q4 25 | — | — | ||
| Q3 25 | $55.8M | — | ||
| Q2 25 | $22.4M | — | ||
| Q1 25 | $74.9M | — | ||
| Q4 24 | $75.0M | — | ||
| Q3 24 | $129.9M | — | ||
| Q2 24 | $92.6M | — | ||
| Q1 24 | $52.0M | — |
自由现金流率KTBRPRX
| Q4 25 | — | — | ||
| Q3 25 | 6.5% | — | ||
| Q2 25 | 3.4% | — | ||
| Q1 25 | 12.0% | — | ||
| Q4 24 | 10.7% | — | ||
| Q3 24 | 19.4% | — | ||
| Q2 24 | 15.3% | — | ||
| Q1 24 | 8.2% | — |
资本支出强度KTBRPRX
| Q4 25 | — | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 1.0% | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.7% | — |
现金转化率KTBRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | 1.74× | 2.44× | ||
| Q2 25 | 0.35× | 12.06× | ||
| Q1 25 | 1.81× | 2.50× | ||
| Q4 24 | 1.28× | 3.57× | ||
| Q3 24 | 1.89× | 1.29× | ||
| Q2 24 | 1.86× | 6.45× | ||
| Q1 24 | 0.95× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KTB
| International Member | $292.0M | 34% |
| CTC Triangle B.V | $192.7M | 23% |
| Lee Segment | $186.7M | 22% |
| Helly Hansen Segment | $185.9M | 22% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
